LOGI-COOL STOCK PLAYS

[Cool_Trades]

6 REASONS WHY IMDS WILL BE TRADING AT $5-10/SHARE IN A YEAR:

- 35 patents capable of GLOBAL monopoly. 20 USA and 15 INTL. JUST 1 of their patents accounts for the CTLM's ability to detect cancer through dense tissue and implants...NO OTHER TECHNOLOGY IN THE WORLD CAN DO THIS! Dense tissue extends into the brain, lungs, etc. and therefore the laser optical imaging technology will be enhancing virtually ALL aspects of the medical diagnostics field!

- 16 distributors in 16 countries ALREADY...not to mention pending Russia approval! They also have FDA EXPORT CERTIFICATION, CE MARKETING (32 countries in Europe), and CHINA approval

- Shimadzu Medical signed on as a distributor, and TODAY updated their website confirming business relationships

http://www.shimadzumedical.com.au/imaging-diagnostic-distribution-agreement-.html

- Each CTLM sells for $495,000 each...the product will monopolize the global mammography market.

- Upon securing non-toxic funding, the company will be immediately applying to the FDA, and the approval will be received BEFORE the usual 90 day review window.

- The breast mammogram market in the USA is controlled by only 4 COMPANIES!! ALL WITH DATED TECHNOLOGY, AND HAZARDOUS!! THE CTLM DOESN'T USE X-RAYS or any other hazardous particle, and no longer needs to squeeze the breast. YOU'RE LOOKING AT PATIENT SATISFACTION, SAFETY, and NO UN-NEEDED BIOPSIES as it has been CLINICALLY PROVEN the CTLM is up to 90% more effective than anything on the market TODAY!

There are 10,000 mammogram centers in the USA alone, each machine sells at a retail price of $495,000 each...now...think of the rest of the world